Disparities in Retinoblastoma Presentation, Treatment, and Outcomes in Developed and Less-Developed Countries

REFERENCES

• Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene 206;25:5341–5349.
   Google Scholar
• MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2092–2102.
   Google Scholar
• Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643–646.
   PubMed Web of Science ®Google Scholar
• Naseripour M. “Retinoblastoma survival disparity”: The expanding horizon in developing countries. Saudi J Ophthalmol 2012;26:157–161.
   PubMedGoogle Scholar
• Abramson DH. Retinoblastoma in the 20th century: Past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005;46:2683–2691.
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE. Retinoblastoma: Fifty years of progress: The LXXI Edward Jackson Memorial Lecture. Am J Ophthalmol 2014;158:875–891.
   PubMed Web of Science ®Google Scholar
• Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol 2010;94:1432–1436.
   Google Scholar
• Ali MJ, Honavar SG, Reddy VA. Orbital retinoblastoma: Present status and future challenges: A review. Saudi J Ophthalmol 2011;25:159–167.
   PubMedGoogle Scholar
• Ang CL, Chee S-P, Jap AH, Tan DTH, Wong T-Y. Clinical Ophthalmology: An Asian Perspective; Singapore: Saunders Elsevier, 2005.
   Google Scholar
• Rahman A. Dilemma in management of retinoblastoma. Journal of Community Medicine and Health Education 2014;4:5.
   Google Scholar
• Bowman RJC, Mafwiri M, Luthert P, Luande J, Wood M. Outcome of retinoblastoma in east Africa. Pediatric Blood & Cancer 2008;50:160–162.
   PubMed Web of Science ®Google Scholar
• Mouratova T. Retinoblastoma in Uzbekistan. Bull Soc Belge Ophtalmol 2003;63-69.
   Google Scholar
• Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 2006;17:228–234.
   PubMed Web of Science ®Google Scholar
• Moreno F, Sinaki B, Fandino A, Dussel V, Orellana L, et al. A population-based study of retinoblastoma incidence and survival in Argentine children. Pediatr Blood Cancer 2014;61:1610–1615.
   Google Scholar
• Schultz KR, Ranade S, Neglia JP, Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer 1993;72:282–286.
   PubMed Web of Science ®Google Scholar
• Moll AC, Kuik DJ, Bouter LM, Den Otter W, Bezemer PD, et al. Incidence and survival of retinoblastoma in The Netherlands: A register based study 1862–1995. Br J Ophthalmol 1997;81:559–562.
   PubMed Web of Science ®Google Scholar
• Orjuela M. Epidemiology. In: C. Rodriguez-Galindo, M.W. Wilson (eds.), Retinoblastoma; New York, NY: Springer; 11–23.
   Google Scholar
• Dean M, Bendfeldt G, Lou H, Giron V, Garrido C, et al. Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala. Cancer Lett 2014;351:59–63.
   PubMed Web of Science ®Google Scholar
• Dryja TP, Morrow JF, Rapaport JM. Quantification of the paternal allele bias for new germline mutations in the retinoblastoma gene. Hum Genet 1997;100:446–449.
   PubMed Web of Science ®Google Scholar
• Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996;52:682–703.
   PubMed Web of Science ®Google Scholar
• Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 2008;112:416–432.
   PubMed Web of Science ®Google Scholar
• Fajardo-Gutierrez A, Juarez-Ocana S, Gonzalez-Miranda G, Palma-Padilla V, Carreon-Cruz R, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: Importance of the Cancer registry (a population-based study). BMC Cancer 2007;7:68.
   PubMed Web of Science ®Google Scholar
• Mohammed AZ, Edino ST, Ochicha O, Gwarzo AK, Samaila AA. Cancer in Nigeria: A 10-year analysis of the Kano cancer registry. Niger J Med 2008;17:280–284.
   PubMedGoogle Scholar
• Green DM. Diagnosis and Management of Malignant Solid Tumors in Infants and Children; Boston, MA: Nijhoff Publishers, 1985.
   Google Scholar
• Gunderson LL. Clinical Radiation Oncology, 4th ed.; Philadelphia: Elsevier, 2012.
   Google Scholar
• Rodrigues KE, Latorre MR, de Camargo B. [Delayed diagnosis in retinoblastoma]. J Pediatr (Rio J) 2004;80:511–516.
   PubMedGoogle Scholar
• Dimaras H, Dimba EA, Gallie BL. Challenging the global retinoblastoma survival disparity through a collaborative research effort. Br J Ophthalmol 2010;94:1415–1416.
   Google Scholar
• Menon BS, Alagaratnam J, Juraida E, Mohamed M, Ibrahim H, et al. Late presentation of retinoblastoma in Malaysia. Pediatr Blood Cancer 2009;52:215–217.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Ellsworth RM, Grumbach N, Sturgis-Buckhout L, Haik BG. Retinoblastoma: Correlation between age at diagnosis and survival. J Pediatr Ophthalmol Strabismus 1986;23:174–177.
   PubMedGoogle Scholar
• Chantada GL, Luna-Fineman S, Qaddoumi I, Furmanchuk A, Wilimas J. Retinoblastoma in developing countries. In: C. Rodriguez-Galindo, M.W. Wilson (eds.), Retinoblastoma; New York, NY: Springer, 2010; 133–141.
   Google Scholar
• Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatr Genet 1989;10:179–184.
   PubMed Web of Science ®Google Scholar
• Nyamori JM, Kimani K, Njuguna MW, Dimaras H. Retinoblastoma referral pattern in Kenya. Middle East Afr J Ophthalmol 2014;21:321–327.
   PubMedGoogle Scholar
• Leal-Leal C, Flores-Rojo M, Medina-Sanson A, Cerecedo-Diaz F, Sanchez-Felix S, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol 2004;88:1074–1077.
   Google Scholar
• Chantada G, Fandino A, Manzitti J, Urrutia L, Schvartzman E. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child 1999;80:171–174.
   PubMed Web of Science ®Google Scholar
• Goddard AG, Kingston JE, Hungerford JL. Delay in diagnosis of retinoblastoma: Risk factors and treatment outcome. Br J Ophthalmol 1999;83:1320–1323.
   Google Scholar
• Wirix M, Parys-Vanginderdeuren R, Casteels I, Uyttebrouck A. Delayed diagnosis of retinoblastoma. Bull Soc Belge Ophtalmol 2000;37–41.
   Google Scholar
• Butros LJ, Abramson DH, Dunkel IJ. Delayed diagnosis of retinoblastoma: Analysis of degree, cause, and potential consequences. Pediatrics 2002;109:E45.
   PubMed Web of Science ®Google Scholar
• Kaimbo WK, Mvitu MM, Missotten L. Presenting signs of retinoblastoma in Congolese patients. Bull Soc Belge Ophtalmol 2002;37–41.
   Google Scholar
• Chang CY, Chiou TJ, Hwang B, Bai LY, Hsu WM, et al. Retinoblastoma in Taiwan: Survival rate and prognostic factors. Jpn J Ophthalmol 2006;50:242–249.
   PubMed Web of Science ®Google Scholar
• Carrim ZI, Kajaige J, Bowman RJ, Lavy TE, Scanlan P. First-year experience of chemotherapy for advanced retinoblastoma in Tanzania: Disease profile, outcomes, and challenges in 2008. J Pediatr Ophthalmol Strabismus 2012;49:176–183.
   PubMed Web of Science ®Google Scholar
• Bhurgri Y, Muzaffar S, Ahmed R, Ahmed N, Bhurgri H, et al. Retinoblastoma in Karachi, Pakistan. Asian Pac J Cancer Prev 2004;5:159–163.
   PubMedGoogle Scholar
• Kashyap S, Meel R, Pushker N, Sen S, Bakhshi S, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer 2012;58:356–361.
   PubMed Web of Science ®Google Scholar
• Saiju R, Thakur J, Karmacharya PC, Shah DN. Retinoblastoma in Nepal: A clinical profile of 30 cases. Nepal Med Coll J 2006;8:171–175.
   PubMedGoogle Scholar
• Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol 1980;98:1204–1210.
   Google Scholar
• Suckling RD, Fitzgerald PH, Stewart J, Wells E. The incidence and epidemiology of retinoblastoma in New Zealand: A 30-year survey. Br J Cancer 1982;46:729–736.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, et al. Presenting signs of retinoblastoma. J Pediatr 1998;132:505–508.
   PubMed Web of Science ®Google Scholar
• Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Experiment Ophthalmol 2005;33:386–389.
   PubMed Web of Science ®Google Scholar
• Poyiadjis S. Time delay in the presentation of solid tumours in developing countries. Pediatric Blood & Cancer 2004;43:305–503.
   PubMedGoogle Scholar
• Hilgartner HL. Report of case of double glioma treated with X-ray. 1903. Tex Med 2005;101:10.
   Google Scholar
• Saiju R, Moore G, Shrestha U, Shrestha MK, Ruit S. Retinoblastoma: Geographic distribution and presentation at a tertiary eye care centre in Kathmandu, Nepal. Nepal J Ophthalmol 2013;5:169–176.
   PubMedGoogle Scholar
• Owoeye JF, Afolayan EA, Ademola-Popoola DS. Retinoblastoma: A clinico-pathological study in Ilorin, Nigeria. Afr J Health Sci 2006;13:117–123.
   PubMedGoogle Scholar
• Carlos LL, Roberto RL, Victor TG, Carlos HG, Eduardo LP. Risk of dying of retinoblastoma in Mexican children. Med Pediatr Oncol 2002;38:211–213.
   PubMedGoogle Scholar
• Chantada GL. Retinoblastoma: Lessons and challenges from developing countries: Ellsworth Lecture 2011. Ophthalmic Genet 2011;32:196–203.
   PubMed Web of Science ®Google Scholar
• Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer 2011;56:341–348.
   PubMed Web of Science ®Google Scholar
• Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer 2007;49:941–946.
   PubMed Web of Science ®Google Scholar
• Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet 2009;30:31–36.
   PubMed Web of Science ®Google Scholar
• Bekibele CO, Ayede AI, Asaolu OO, Brown BJ. Retinoblastoma: The challenges of management in Ibadan, Nigeria. J Pediatr Hematol Oncol 2009;31:552–555.
   PubMed Web of Science ®Google Scholar
• Ka AS, Imbert P, Diagne I, Seye MN, Gerardin P, et al. [Epidemiology and prognosis of childhood injuries in Dakar, Senegal]. Med Trop (Mars) 2003;63:533–538.
   PubMedGoogle Scholar
• Chantada GL, Dunkel IJ, Antoneli CB, de Davila MT, Arias V, et al. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer 2007;49:256–260.
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA. Retinoblastoma management: Advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol 2010;21:203–212.
   PubMed Web of Science ®Google Scholar
• Dhar SU, Chintagumpala M, Noll C, Chevez-Barrios P, Paysse EA, et al. Outcomes of integrating genetics in management of patients with retinoblastoma. Arch Ophthalmol 2011;129:1428–1434.
   Google Scholar
• Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: Four-year experience. Arch Ophthalmol 2011;129:732–737.
   PubMed Web of Science ®Google Scholar
• Chantada GL, Fandino AC, Raslawski EC, Manzitti J, de Davila MT, et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer 2005;44:455–460.
   PubMed Web of Science ®Google Scholar
• Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, et al. Treatment of retinoblastoma patients with chemoreduction plus local therapy: Experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol 2006;28:342–345.
   PubMed Web of Science ®Google Scholar
• Gunduz K, Gunalp I, Yalcindag N, Unal E, Tacyildiz N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 2004;111:1917–1924.
   Google Scholar
• Chantada GL, Dunkel IJ, Qaddoumi I, Antoneli CB, Totah A, et al. Familial retinoblastoma in developing countries. Pediatr Blood Cancer. 2009;338–342.
   Google Scholar
• Shanmugam MP, Biswas J, Gopal L, Sharma T, Nizamuddin SH. The clinical spectrum and treatment outcome of retinoblastoma in Indian children. J Pediatr Ophthalmol Strabismus 2005;42:75–81; quiz 112–113.
   PubMed Web of Science ®Google Scholar
• Gallie BL, Zhao J, Vandezande K, White A, Chan HS. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer 2007;49:1083–1090.
   Google Scholar
• Leander C, Fu LC, Pena A, Howard SC, Rodriguez-Galindo C, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007;49:817–819.
   PubMed Web of Science ®Google Scholar
• Wilimas JA, Wilson MW, Haik BG, Barnoya M, Fu L, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009;53:42–46.
   PubMed Web of Science ®Google Scholar
• Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471–2475.
   Google Scholar
• Kodilinye HC Retinoblastoma in Nigeria: Problems of treatment. Am J Ophthalmol 1967;63:469–481.
   PubMed Web of Science ®Google Scholar
• Nasution R, Sutjipto A. Childhood retinoblastoma. Paediatr Indones 1991;31:117–122.
   PubMedGoogle Scholar
• Qaddoumi I, Nawaiseh I, Mehyar M, Razzouk B, Haik BG, et al. Team management, twinning, and telemedicine in retinoblastoma: A 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer 2008;51:241–244.
   PubMed Web of Science ®Google Scholar